Stoke Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 05/15/2026 | 5.62 M | $183.10 M | 1.38% | 8.92% |
| BLACKROCK, INC. | 05/13/2026 | 5.39 M | $175.36 M | 3.32% | 8.54% |
| FMR LLC | 05/15/2026 | 5.38 M | $175.29 M | -3.88% | 8.54% |
| LYNX1 CAPITAL MANAGEMENT LP | 05/04/2026 | 4.76 M | $155.11 M | -11.86% | 7.55% |
| REDMILE GROUP, LLC | 05/15/2026 | 4.16 M | $135.58 M | 3.22% | 6.60% |
| MORGAN STANLEY | 05/15/2026 | 3.42 M | $111.46 M | -3.47% | 5.43% |
| BAKER BROS. ADVISORS LP | 05/15/2026 | 3.34 M | $108.64 M | 0.00% | 5.29% |
| TORONTO DOMINION BANK | 05/15/2026 | 3.17 M | $103.32 M | 0.00% | 5.03% |
| WELLINGTON MANAGEMENT GROUP LLP | 05/15/2026 | 3.10 M | $100.80 M | 320.73% | 4.91% |
| BVF INC/IL | 05/15/2026 | 2.55 M | $82.95 M | 12.44% | 4.04% |
| VANGUARD CAPITAL MANAGEMENT LLC | 05/15/2026 | 2.36 M | $76.70 M | 100.00% | 3.74% |
| STATE STREET CORP | 05/15/2026 | 2.28 M | $74.12 M | -8.87% | 3.61% |
| SIREN, L.L.C. | 05/14/2026 | 2.00 M | $64.97 M | -11.21% | 3.16% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 1.93 M | $62.98 M | 419.47% | 3.07% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 05/15/2026 | 1.82 M | $59.37 M | 0.00% | 2.89% |
| JANUS HENDERSON GROUP PLC | 05/18/2026 | 1.61 M | $52.46 M | 11.15% | 2.56% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 1.32 M | $43.06 M | 13.39% | 2.10% |
| POLAR CAPITAL HOLDINGS PLC | 05/15/2026 | 1.13 M | $36.87 M | -10.76% | 1.80% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 989.94 K | $32.23 M | 19.68% | 1.57% |
| ASSENAGON ASSET MANAGEMENT S.A. | 04/20/2026 | 907.02 K | $29.53 M | -26.12% | 1.44% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 830.70 K | $27.05 M | -27.31% | 1.32% |
| BIOIMPACT CAPITAL LLC | 05/15/2026 | 767.04 K | $24.97 M | -0.42% | 1.22% |
| OPALEYE MANAGEMENT INC. | 05/15/2026 | 700.00 K | $22.79 M | 0.72% | 1.11% |
| TROLUCE CAPITAL ADVISORS LLC | 05/15/2026 | 652.80 K | $21.26 M | 100.00% | 1.04% |
| BAILLIE GIFFORD & CO | 05/08/2026 | 575.18 K | $18.73 M | 132.96% | 0.91% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 543.10 K | $17.68 M | 163.43% | 0.86% |
| CANDRIAM S.C.A. | 04/30/2026 | 502.02 K | $16.35 M | 12.39% | 0.80% |
| TANG CAPITAL MANAGEMENT LLC | 05/15/2026 | 500.00 K | $16.28 M | 0.00% | 0.79% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 472.14 K | $15.37 M | 100.00% | 0.75% |
| 05/08/2026 | 462.68 K | $15.06 M | 100.00% | 0.73% | |
| ERSTE ASSET MANAGEMENT GMBH | 05/11/2026 | 446.00 K | $14.17 M | 12.63% | 0.71% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 437.18 K | $14.23 M | 6.39% | 0.69% |
| NORTHERN TRUST CORP | 05/14/2026 | 431.63 K | $14.05 M | 7.06% | 0.68% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 356.95 K | $11.62 M | 100.00% | 0.57% |
| PARKMAN HEALTHCARE PARTNERS LLC | 05/15/2026 | 336.52 K | $10.96 M | -21.77% | 0.53% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 05/15/2026 | 335.59 K | $10.93 M | 75.34% | 0.53% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 05/13/2026 | 315.49 K | $10.27 M | 100.00% | 0.50% |
| JPMORGAN CHASE & CO | 05/13/2026 | 265.47 K | $8.43 M | -4.48% | 0.42% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 05/15/2026 | 250.91 K | $8.17 M | 100.00% | 0.40% |
| BIRCHVIEW CAPITAL, LP | 05/15/2026 | 210.00 K | $6.84 M | -19.23% | 0.33% |
| CAPTION MANAGEMENT, LLC | 05/15/2026 | 200.00 K | $6.51 M | 100.00% | 0.32% |
| FIRST TRUST ADVISORS LP | 05/13/2026 | 163.46 K | $5.32 M | 0.48% | 0.26% |
| UBS GROUP AG | 05/05/2026 | 158.30 K | $5.15 M | -6.72% | 0.25% |
| INVESCO LTD. | 05/12/2026 | 150.05 K | $4.89 M | -42.19% | 0.24% |
| BANK OF NEW YORK MELLON CORP | 05/05/2026 | 143.41 K | $4.67 M | 1.85% | 0.23% |
| FRANKLIN RESOURCES INC | 05/13/2026 | 142.79 K | $4.65 M | 7.99% | 0.23% |
| DAFNA CAPITAL MANAGEMENT LLC | 05/15/2026 | 130.88 K | $4.26 M | 20.21% | 0.21% |
| CITADEL ADVISORS LLC | 05/15/2026 | 123.02 K | $4.01 M | 676.12% | 0.20% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 05/15/2026 | 119.23 K | $3.88 M | -5.64% | 0.19% |
| GILDER GAGNON HOWE & CO LLC | 05/15/2026 | 112.63 K | $3.67 M | -8.02% | 0.18% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Stoke Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 235 institutional investors and hedge funds held shares of Stoke Therapeutics Inc. The most heavily invested institutionals were:
Assenagon Asset Management S.A.: 1.13 M
BAILLIE GIFFORD & CO: 517,275
Erste Asset Management GmbH: 428,381
Bank of New York Mellon Corp: 164,273
PRINCIPAL FINANCIAL GROUP INC: 69,880
CITIGROUP INC: 69,326
120.08% of Stoke Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 100.57 M shares in the last 24 months. This purchase volume represents approximately $3.85 B in transactions.